A study funded by the NIHR Health Technology Assessment (HTA) Programme published in The New England Journal of Medicine, recommends that high frequency oscillatory ventilation (HFOV) should not be used in the routine care of adult patients with acute respiratory distress syndrome. The OSCAR study, led by Dr Duncan Young of the University of Oxford, trialled the use of HFOV in patients with acute respiratory distress syndrome.  Patients with severe pneumonia and other acute lung disorders require artificial ventilation, and while current techniques do this successfully, they have unwanted side effects.